Literature DB >> 2469122

Immunologic aspects of mycobacterial infections.

J J Ellner1, R S Wallis.   

Abstract

Immunosuppressive mechanisms loom as important factors in depression of delayed-type hypersensitivity responses during active tuberculosis. Nonspecific suppression may be mediated by circulating immune complexes containing mycobacterial polysaccharides such as D-arabino-D-galactan. The mechanism of suppression involves activation of monocyte production of immunosuppressive prostaglandin E2. Peripheral blood mononuclear cells from patients with tuberculosis include increased numbers of monocytes that suppress the response to tuberculin purified protein derivative (PPD). Antigen-specific suppression is associated with monocyte activation by a number of criteria, including decreased surface expression of HLA-DR determinants and increased production of interleukin 1 (IL-1). The increased production of IL-1 is associated with--and may have a causal relation to--immunosuppression. A second parallel regulatory mechanism involves PPD-specific suppression by Fc gamma receptor-bearing lymphocytes. The consequence of these immunosuppressive circuits is depression of tuberculin-induced blastogenesis, production of IL-2, and generation of IL-2 receptors. These findings suggest that natural infection with Mycobacterium tuberculosis may result in immunosuppression. Studies of potentially protective antigens in experimental systems must be designed to assess and avoid activation of suppressor circuits.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2469122     DOI: 10.1093/clinids/11.supplement_2.s455

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  16 in total

1.  Regulation of T-cell proliferative responses by cells from solid lung tissue of M. tuberculosis-infected mice.

Authors:  A S Apt; I B Kramnik; A M Moroz
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  Intracranial tuberculoma developing during therapy for tuberculous meningitis.

Authors:  J L Malone; S Paparello; L S Rickman; K F Wagner; B Monahan; E C Oldfield
Journal:  West J Med       Date:  1990-02

3.  Depletion of endogenous interleukin-10 augments interleukin-1 beta secretion by Mycobacterium bovis BCG-reactive human cells.

Authors:  P Méndez-Samperio; E Garcia-Martinez; M Hernandez-Garay; M Solis-Cardona
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

4.  Protein deficiency induces alterations in the distribution of T-cell subsets in experimental pulmonary tuberculosis.

Authors:  E S Mainali; D N McMurray
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

5.  Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.

Authors:  D M Underhill; A Ozinsky; K D Smith; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

6.  Ultraviolet-irradiated monocytes efficiently inhibit the intracellular replication of Mycobacterium avium intracellulare.

Authors:  W S Mirando; H Shiratsuchi; K Tubesing; H Toba; J J Ellner; C A Elmets
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

7.  Mycobacterial infections in AIDS.

Authors:  A R Hill
Journal:  Can J Infect Dis       Date:  1991

8.  Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components.

Authors:  Y Zhang; M Doerfler; T C Lee; B Guillemin; W N Rom
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis.

Authors:  S Carlucci; A Beschin; L Tuosto; F Ameglio; G M Gandolfo; C Cocito; F Fiorucci; C Saltini; E Piccolella
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

10.  Erythrocyte receptor (CD2)-bearing T lymphocytes are affected by diet in experimental pulmonary tuberculosis.

Authors:  R A Bartow; D N McMurray
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.